129
Views
59
CrossRef citations to date
0
Altmetric
Original Article

Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid

, , &
Pages 348-362 | Received 02 Jun 1997, Accepted 22 Dec 1997, Published online: 02 Jul 2009

References

  • Tschesche, H., Knauper, V., Kramer, S., Micahelis, J., Oberhoff, R. and Reinke, H. (1992) Latent collagenase and gelatinase from human neutrophils and their activation. MATRIX, (Suppl. 1), 245–255.
  • Bergenfeldt, M., Axelsson, L. and Ohlsso, K. (1992) Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scandinavian Journal of Clinical & Laboratory Investigation, 52, 823–829.
  • Rao, N. V., Rao, G. V., Marshall, B. C. and Hoidal, J. R. (1996) Biosynthesis and processing of proteinase 3 in U937 Cells. J. Biol. Chem. 271, 2972–2978.
  • Olsson, I. and Venge, P. (1980) The role of the human neutrophil in the inflammatory reaction. Allergy, 35, 1–13.
  • Janoff, A. (1985) Elastase in tissue injury. (Review). Ann. Rev. Med. 36, 207–216.
  • Maldonado, B. A. and Furcht, L. T. (1995) Involvement of integrins with adhesion-promoting, heparin-binding peptides of type IV collagen in cultured human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 36, 364–372.
  • Itoh, Y. and Nagase, H. (1995) Preferential inactivation of tissue inhibitor of metalloproteases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J. Biol. Chem. 270, 16518–16521.
  • Twining, S. S., Kirschner, S. E., Mahnke, L. A. and Frank, D. W. (1993) Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest. Ophthalmol. Vis. Sci. 34, 2699–2712.
  • Fryksmark, U., Jannert, M., Ohlsson, K., Tegner, H. and Wihl, J. A. (1989) Secretory leukocyte protease inhibitor in normal, allergic and virus induced nasal secretions. Rhinology, 27, 97–103.
  • Sepper, R., Konttinen, Y. T., Ingman, T. and Sorsa, T. (1995) Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis. J. Clin. Immunol. 15, 27–34.
  • Birrer, P. (1995) Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies. (Review). Respiration, 62 (Suppl. 1), 25–28.
  • Nadziejko, C., Finkelstein, L. and Balmes, J. R. (1995) Contribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation. Am. J. Resp. Crit. Care Med. 152, 1592–1598.
  • Alkemade, H. A., de Jongh, G. J., Aronold, W. P., van de Kerkhof, P. C. and Schalkwijk, J. (1995) Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. Journal of Investigative Dermatology, 104, 189–193.
  • Rao, N. V., Marshall, B. C., Gray, B. H. and Hoidal, J. R. (1993) Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am. J. Resp. Cell Mol. Biol. 8, 612–616.
  • Tompson, R. C. and Ohlsson, K. (1986) Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA, 83, 6692–6696.
  • Ying, Q. L. and Simon, S. R. (1993) Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin. Biochemistry, 32, 1866–1874.
  • Wiedow, O., Luademann, J. and Utecht, B. (1991) Elafin is a potent inhibitor of proteinase 3. Biochem. Bioph. Res. Co. 174, 6–10.
  • Steinert, P. M. and Marekov, L. N. (1995) The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem. 270, 17702–17711.
  • Prause, J. U. (1983) Serum albumin, serum antiproteases and polymorphonuclear leukocyte neutral collagenolytic protease in the tear fluid of patients with corneal ulcers. Acta Ophthalmol. 61, 272–282.
  • Prause, J. U. (1984) Cellular and biochemical mechanisms involved in the degradation and healing of the cornea. The polymorphonuclear leukocyte and tear fluid serum antiproteases in human melting central corneal ulcers. Acta Ophthalmol. 168 (Suppl.), 1–40.
  • Seng, W. L., Glogowski, J. A., Wolf, G., Berman, M. B., Kenyon, K. R. and Kiorpes, T. C. (1980) The effect of thermal bums on the release of collagenase from corneas of vitamin A-deficient and control rats. Invest. Ophthalmol. Vis. Sci. 19, 1461–1470.
  • Kao, W. W. Y., Ebert, J., Kao, C. W. C., Covington, H. and Cintron, C. (1986) Development of monoclonal antibodies recognizing collagenase from rabbit PMN; the presence of this enzyme in ulcerating corneas. Curr. Eye Res. 5, 801–815.
  • Campbell, R., Pavan-Langston, D., Lass, J., Berman, M., Gage, J. and Albert, D. (1980) Collagenase levels in a new model of experimental herpetic interstitial keratitis. Arch. Ophthalmol. 98, 919–923.
  • Elgebaly, S. A., Downes, R. T., Bohr, M., Forouhar, F., O'Rourke, J. and Kreutzer, D. L. (1987) Inflammatory mediators in alkali-burned corneas: preliminary characterization. Curr. Eye Res. 6, 1263–1274.
  • Berta, A. (1992) Enzymology of the tears. CRC Press, Boca Raton, FL.
  • Cejkova, J., Lojda, Z., Vacik, J., Digenis, G. A. and Dropcova, S. (1992) Histochemical changes in the rabbit cornea and plasmin activity in the tear fluid during contact lens wear. Favourable influence of protease inhibitors (aprotinin, PC5, elastatinal). Histochemistry, 97, 69–76.
  • Prause, J. U. (1983) Serum albumin, serum antiproteases and polymorphonuclear leucocyte neutral collagenolytic protease in the tear fluid of normal healthy persons. Acta Ophthalmol. 61, 261–271.
  • Berta, A., Vamosi, P. and Tozser, J. (1989) Eine neue methode zur semiquantitativen alpha-1-antitrypsinbestimmung in der menschlichen tranenflussigkeit. Fortsch. Ophthalmol. 86, 773–776.
  • Leib, M. L., Shuster, J., Little, J. M. and Lorenzetti, D. W. C. (1980) The determination of alpha-2-macroglobulin in tears by laser nephelometry. (Abstract). Invest. Ophthalmol. Vis. Sci. 19 (Suppl.), 201.
  • Kalashnikov, V. V., Platonova, T. K. and Svishchev, A. V. (1990) Immunofermentnyi metod opredeleniia alpha2-makroglobulina cheloveka. Voprosy Meditsinskoi Khimii. 36, 83–85.
  • Sen, D. K. and Sarin, G. S. (1986). Tear and serum alpha-1 antitrypsin levels in corneal and conjuctival diseases. In The Preocular Tear Film in Health, Disease and Contact Lens Wear ( Eds. Holly, F. J.). pp. 192–199. Dry Eye Institute, Lubbock, TX, USA.
  • Berman, M. B., Barber, J. C., Talamo, R. C. and Langley, C. E. (1973) Corneal ulceration and the serum antiproteases: 1. alpha 1-antitrypsin. Invest. Ophthalmol. Vis. Sci. 12, 759–770.
  • Chesnokova, N. B. and Maichuk, Y. F. (1986) Antiproteases in herpetic keratitis. Metabolic, Pediatric & Systemic Ophthalmology, 9, 593–596.
  • Manners, R. M., Donaldson, M. L., Low, C. and Fenton, P. J. (1994) Corneal ulceration in a patient with alpha 1 antitrypsin deficiency. Brit. J. Ophthalmol. 78, 653–654.
  • Rennert, O. M., Kaiser, D., Sollberger, H. and Joller-Jemelka, S. (1974) Antiprotease activity in tears and nasal secretions. Humangenetik, 23, 73–77.
  • van Setten, G. B., Nilsson, L., Hahne, S., Johnston, J. A., Kvanta, A., Gandy, S. E., Naslund, J. and Nordstedt, C. (1996) Beta–amyloid protein precursor expression in lacrimal glands and tear fluid. Invest. Ophthalmol. Vis. Sci. 37, 2585–2593.
  • Kueppers, F. (1971) Proteinase inhibitor in human tears. Biochim. Biophys. Acta, 299, 845–849.
  • Franken, C., Meijer, C. J. L. M. and Dijkman, J. H. (1989) Tissue distribution of antileukoprotease and lysozyme in humans. J. Histochem. Cytochem. 37, 493–498.
  • Kramps, J. A., Franken, C. and Dijkman, J. H. (1984) Elisa for quantitative measurement of low molecular weight bronchial protease inhibitor in human sputum. Am. Rev. Resp. Dis. 129, 959–963.
  • Melrose, J. and Ghosh, P. (1992) Development of an avidinbiotin competitive inhibition assay and validation of its use for the quantitation of human intervertebral disc serine proteinase inhibitory proteins. Anal. Biochem. 204, 372–382.
  • Sack, R. A., Sathe, S., Hackworth, L. A., Willcox, M. D., Holden, B. A. and Morris, C. A. (1996) The effect of eye closure on protein and complement deposition on Group IV hydrogel contact lenses: relationship to tear flow dynamics. Curr. Eye Res. 15, 1092–1100.
  • Sack, R. A., Tan, K. O. and Tan, A. (1992) Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 33, 626–640.
  • Tan, K. O., Sack, R. A., Holden, B. A. and Swarbrick, H. A. (1993) Temporal sequence of changes in tear film composition during sleep. Curr. Eye Res. 12, 1001–1007.
  • Thakur, A., Willcox, M. D. P., Morris, C. and Holden, B. A. (1996) Inflammatory mediators of tear fluid and their role in corneal inflammation. (Abstract). Invest. Ophthalmol. Vis. Sci. 37 (Suppl.), S234.
  • Sack, R. A., Bogart, B. I., Beaton, A., Sathe, S. and Lew, G. (1997) Diurnal variations in tear glycoproteins. Evidence for an epithelial origin for the major non-reducible ≥450 kDa sialoglycoprotein(s). Curr. Eye Res. 16, 577–588.
  • Sack, R. A., Underwood, P. A., Tan, K. O., Sutherland, H. and Morris, C. A. (1993) Vitronectin-possible contribution to the closed-eye external host-defense mechanism. Ocul. Immunol. Inflam. 1, 327–336.
  • Willcox, M. D. P., Morris, C. A., Thakur, A., Sack, R. A., Wickson, J. and Boey, W. (1997) Complement and complement regulatory proteins in human tears. Invest. Ophthalmol. Vis. Sci. 38, 1–8.
  • Sakata, M., Sack, R. A., Sathe, S., Holden, B. and Beaton, A. (1997) Polymorphonuclear leukocyte cells and elastase in tears. Curr. Eye Res. 16, 810–819.
  • Punyiezki, M., Berta, A. and Tozser, J. (1988) Study of neutral proteinases of human tear samples using gels containing copolymerized substrates. Clin. Chem. Enzym. Comms. 1, 115–124.
  • Tsung, P. K. and Holly, F. J. (1981) Protease activities in human tears. Curr. Eye Res. 1, 351–355.
  • Tervo, T., Salonen, E. M., Vahen, A., Immonen, I., van Setten, G. B., Himberg, J. J. and Tarkkanen, A. (1988) Elevation of tear fluid plasmin in corneal disease. Acta Ophthalmol. (Copenh.), 66, 393–399.
  • Berta, A. (1986) Standardization of tear protein determinations: the effects of sampling, flow rate, and vascular permeability. In The Preocular Tear Film in Health, Disease and Contact Lens Wear ( Eds. Holly, F. J.). pp. 418–433. Dry Eye Institute, Lubbock, TX, USA.
  • Fullard, R. J. and Snyder, C. (1990) Protein levels in non-stimulated and stimulated tears of normal human subjects. Invest. Ophthalmol. Vis. Sci. 31, 1119–1126.
  • Fernandez-Resa, P., Mira, E. and Quesada, A. R. (1995) Enhanced detection of casein zymography of matrix metalloproteinases. Anal. Biochem. 224, 434–435.
  • Heussen, C. and Dowdle, E. B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196–202.
  • Poethke, R., Mader, M., Zedler, L., Beuche, W., Felgenhauer, K. and Kolbus, N. (1996) A putative enzyme from various secretions specifically inhibits antibody-antigen interactions. J. Immunol. Methods, 191, 149–157.
  • Meijer, F. and Van Haeringen, N. J. (1993) Separation and characteristics of glycoproteins in tears which inhibit coating and precipitation of protein. Curr. Eye Res. 12, 531–538.
  • Bogart, B. I., Lew, G., Same, S. and Sack, R. (1997) Lipocalin as a component of human tears surface active substances. Invest. Ophthalmol. Vis. Sci. 38 (Suppl.), S941.
  • Kowal, K. and Weinstein, A. (1994) Western blot band intensity analysis. Application to the diagnosis of Lyme arthritis. Arthritis & Rheumatism, 37, 1206–1211.
  • Velleman, S. G. (1995) Quantifying immunoblots with a digital scanner. BioTechniques, 18, 1056–1058.
  • Venembre, P., Seta, N., Boutten, A., Dehoux, M., Aubier, M. and Durand, G. (1994) Comparison of enhanced chemiluminescence and calorimetric techniques for the immuno-detection of α1-antitrypsin. Clinica Chimica Acta, 221, 175–184.
  • Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
  • Stockley, R. A. and Afford, S. C. (1984) The effect of leucocyte elastase on the immunoelectrophoretic behaviour of alpha 1-antitrypsin. Clin. Sci. 66, 217–224.
  • Tschesche, H., Englebrecht, S. and Wenzel, H. R. (1984) Leukocyte elastase. In Methods of Enzymatic Analysis, Volume V, , 3rd ed ( Eds. Bergmeyer, H. U.). pp. 176–184. Weinheim Publishers, Deerfield Beach, FL, USA.
  • Takeuchi, K. H. (1991) Biochemical and immunological identification of human neutrophil elastase on nitrocellulose membranes. Biotech & Histochem. 66, 324–329.
  • Szewczyk, B. and Kozloff, L. M. (1985) A method for the efficient blotting of strongly basic proteins from sodium dodecyl sulfate-polyacrylamide gels to nitrocellulose. Anal. Biochem. 150, 403–407.
  • Baslund, B., Peterson, J., Permin, H., Wiik, A. and Wieslander, J. (1994) Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. Journal of Immunological Methods, 175, 215–225.
  • Chignard, M., Hazouard, E., Renesto, P., Laine, A., Guidet, B. and Offenstadt, G. (1995) Plasma antiproteinase screen and neutrophil-mediated platelet activation. A major role played by alpha 1 antitrypsin. Biochimica et Biophysica Acta, 1224, 433–440.
  • Swenson, R. P. and Howard, J. B. (1979) Structural characterization of human α2-macroglobulin subunits. J. Biol. Chem. 254, 4452–4456.
  • Lane, A., Davril, M., Rabaud, M., Vercaigne-Marko, D. and Hayem, A. (1985) Human serum α1-antichymotrypsin is an inhibitor of pancreatic elastases. Eur. J. Biochem. 151, 327–331.
  • Travis, J., Bowen, J. and Baugh, R. (1978) Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry, 17, 5651–5156.
  • van Haeringen, N. J. (1981) Clinical biochemistry of tears. Surv. Ophthalmol. 26, 84–96.
  • Kijlstra, A. (1991) The role of lactoferrin in the nonspecific immune response on the ocular surface. (Review). Reg. Immunol. 3, 193–197.
  • Hiemstra, P. S., Maassen, R. J., Stolk, J., Heinzel-Wieland, R., Steffens, G. J. and Dijkman, J. H. (1996) Antibacterial activity of antileukoprotease. Infection & Immunity, 64, 4520–4524.
  • Miller, K. W., Evans, R. J., Eisenberg, S. P. and Thompson, R. C. (1989) Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli. J. Bacteriol. 171, 2166–2172.
  • McNeely, T. B., Dealy, M., Dripps, D. J., Orenstein, J. M., Eisenberg, S. P. and Wahl, S. M. (1995) Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficency virus I activity in vitro. J. Clin. Invest. 96, 456–464.
  • Van-Seuningen, I., Houdret, N., Hayem, A. and Davri, M. (1992) Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions. Int. J. Biochem. 24, 303–311.
  • Van-Seuningen, I., Aubert, J. P. and Davril, M. (1992) Interaction between secretary leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Biochem. J. 281, 761–766.
  • Nadziejko, C. and Finkelstein, I. (1994) Inhibition of neutrophil elastase by mucus glycoprotein. Am. J. Respir. Cell & Mol. Biol. 11, 103–107.
  • Lass, J. H., Walter, E. I., Burris, T. E., Grossniklaus, H. E., Roat, M. I., Skelnik, D. L., Needham, L., Singer, M. and Medof, M. E. (1990) Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest. Ophthalmol. Vis. Sci. 31, 1136–1148.
  • Bora, N. S., Gobleman, C. L., Atkinson, J. P., Pepose, J. S. and Kaplan, H. J. (1993) Differential expression of the complement regulatory proteins in the human eye. Invest. Ophthalmol. Vis. Sci. 34, 3579–3584.
  • Sack, R. A., Sathe, S., Beaton, A. and Nunes, I. (1995) Tear proteases as a function of eye closure. (Abstract). Invest. Ophthalmol. Vis. Sci. 36 (Suppl.), S995.
  • Fry, K., Sack, R. A., Beaton, A., Sathe, S. and Holden, B. (1996) Plasminogen activator inhibitor activities in tear fluid. (Abstract). Invest. Ophthalmol. Vis. Sci. 37 (Suppl.), S847.
  • Twining, S. S., Fukuchi, T., Yue, B. Y., Wilson, P. M. and Boskovic, G. (1994) Corneal synthesis of alpha 1-proteinase inhibitor (alpha 1-antitrypsin). Invest. Ophthalmol. Vis. Sci. 35, 458–462.
  • Twining, S. S., Fukuchi, T., Yue, B. Y., Wilson, P. M., Zhou, X. and Loushin, G. (1994) Alpha 2-macroglobulin is present in and synthesized by the cornea. Invest. Ophthalmol. Vis. Sci. 35, 3226–3233.
  • Twining, S. S., Fukuchi, T., Yue, B. Y., Wilson, P. M. and Zhou, X. (1994) Alpha 1 antichymotrypsin is present in and synthesized by the cornea. Curr. Eye Res. 13, 433–439.
  • Gehring, N. M., Shiels, B. R., Northemann, W., de Bruijn, N. M., Kan, C. C., Chain, A. C., Noonan, D. J. and Fey, G. H. (1987) Sequence of rat liver alpha 2-macroglobulin and acute phase control of its messenger RNA. J. Biol. Chem. 262, 446–454.
  • Abbinante-Nissen, J. M., Simpson, L. G. and Leikauf, G. D. (1995) Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 268, L601–606.
  • Abbinante-Nissen, J. M., Simpson, L. G. and Leikauf, G. D. (1993) Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 265, L286–L292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.